Page 61 - Read Online

Kanmaniraja et al. Hepatoma Res 2020;6:51 I http://dx.doi.org/10.20517/2394-5079.2020.46 Page 11 of 11

20. Choi SH, Byun JH, Kim SY, Lee SJ, Won HJ, et al. Liver Imaging Reporting and Data System v2014 with gadoxetate disodium-enhanced
magnetic resonance imaging: validation of LI-RADS Category 4 and 5 Criteria. Invest Radiol 2016;51:483-90.
21. Chernyak V, Flusberg M, Berman J, Fruitman KC, Kobi M, et al. Liver Imaging Reporting and Data System (LI-RADS) v2018: impact
on categorization and hepatocellular carcinoma staging. Liver Transpl 2019;25:1488-502.
22. Lee SM, Lee JM, Ahn SJ, Kang HJ, Yang HK, et al. LI-RADS Version 2017 versus Version 2018: diagnosis of hepatocellular carcinoma
on gadoxetate disodium-enhanced MRI. Radiology 2019;292:655-63.
23. Ren AH, Zhao PF, Yang DW, Du JB, Wang ZC, et al. Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS
v2018, compared with v2017. J Magn Reson Imaging 2019;50:746-55.
24. Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, et al. AASLD guidelines for the treatment of hepatocellular carcinoma.
Hepatology 2018;67:358-80.
25. Chernyak V, Santillan CS, Papadatos D, Sirlin CB. LI-RADS((R)) algorithm: CT and MRI. Abdom Radiol (NY) 2018;43:111-26.
26. Tang A, Valasek MA, Sirlin CB. Update on the liver imaging reporting and data system: what the pathologist needs to know. Adv Anat
Pathol 2015;22:314-22.
27. Fowler KJ, Tang A, Santillan C, Bhargavan-Chatfield M, Heiken J, et al. Interreader Reliability of LI-RADS Version 2014 algorithm and
imaging features for diagnosis of hepatocellular carcinoma: a large international multireader study. Radiology 2018;286:173-85.
28. Kang JH, Choi SH, Lee JS, Park SH, Kim KW, et al. Interreader agreement of liver imaging reporting and data system on MRI: a
systematic review and meta-analysis. J Magn Reson Imaging 2020; doi: 10.1002/jmri.27065.
29. Chernyak V, Sirlin CB. Editorial for “Interreader Agreement of Liver Imaging Reporting and Data System on MRI: a systematic review
and meta analysis”. J Magn Reson Imaging 2020; doi: 10.1002/jmri.27133.
30. Goldberg-Stein S, Chernyak V. Adding value in radiology reporting. J Am Coll Radiol 2019;16:1292-8.
31. Corwin MT, Lee AY, Fananapazir G, Loehfelm TW, Sarkar S, et al. Nonstandardized terminology to describe focal liver lesions in
patients at risk for hepatocellular carcinoma: implications regarding clinical communication. AJR Am J Roentgenol 2018;210:85-90.
32. Flusberg M, Ganeles J, Ekinci T, Goldberg-Stein S, Paroder V, et al. Impact of a structured report template on the quality of CT and MRI
reports for hepatocellular carcinoma diagnosis. J Am Coll Radiol 2017;14:1206-11.
33. Alenazi AO, Elsayes KM, Marks RM, Yacoub JH, Hecht EM, et al. Clinicians and surgeon survey regarding current and future versions
of CT/MRI LI-RADS. Abdom Radiol (NY) 2020;45:2603-11.